Core Viewpoint - The company Hualu Bio (300970.SZ) has stated that its maitake mushroom products are not currently positioned in the pharmaceutical industry [1] Company Summary - Hualu Bio has clarified its current strategic focus, indicating that it has not yet ventured into the pharmaceutical sector with its maitake mushroom products [1]